Karyoptosis detected in 35% of frontal cortex neurons in end-stage Alzheimer's versus 15% in controls

Researchers at King's College London and the UK Dementia Research Institute examined post-mortem frontal cortex tissue using computational classification of cell-death morphology. They quantified nuclear shrinkage and LaminB1 fragmentation, finding karyoptotic features in 35% of neurons from Alzheimer's cases compared with 15% in age-matched controls. Parallel rat-neuron experiments showed that forcing tau or TDP-43 aggregation activated p38 MAPK, which then phosphorylated LaminB1, destabilizing the nuclear envelope.

Existing literature on apoptosis, necroptosis and ferroptosis has accounted for only a minority of neuron loss in these diseases. The new pathway supplies a mechanistic bridge between the long-observed protein aggregates and the extensive nuclear-envelope rupture seen in patient tissue. Because p38 MAPK inhibitors already exist in clinical pipelines for other indications, the finding immediately suggests repurposing opportunities, yet selectivity for the LaminB1 interaction remains untested in vivo.

The study is limited by its cross-sectional design and reliance on end-stage tissue; longitudinal imaging or conditional mouse models will be required to establish whether karyoptosis precedes or follows other death programs. Future work targeting the p38-LaminB1 interface could clarify whether blocking this step slows cognitive decline in carriers of MAPT or C9orf72 mutations.